M&T Bank’s Antares Pharma, Inc. ATRS Stock Holding History

M&T Bank’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-30,000	Closed	-$99K	–	1670
2019 Q2	$99K	Sell	30,000 -50,000	-63%	-$145K	﹤0.01%	1500
2019 Q1	$242K	Sell	80,000 -50,000	-38%	-$162K	﹤0.01%	1303
2018 Q4	$354K	Buy	130,000 +50,000	+63%	+$165K	﹤0.01%	1046
2018 Q3	$269K	Sell	80,000 -50,000	-38%	-$154K	﹤0.01%	1285
2018 Q2	$335K	Hold	130,000	–	–	﹤0.01%	1171
2018 Q1	$286K	Hold	130,000	–	–	﹤0.01%	1243
2017 Q4	$259K	Hold	130,000	–	–	﹤0.01%	1314
2017 Q3	$421K	Hold	130,000	–	–	﹤0.01%	1065
2017 Q2	$419K	Buy	130,000 +50,000	+63%	+$142K	﹤0.01%	1049
2017 Q1	$227K	Buy	+80,000	New	+$192K	﹤0.01%	1407
2015 Q3	–	Sell	-11,310	Closed	-$24K	–	2073
2015 Q2	$24K	Buy	+11,310	New	+$27.4K	﹤0.01%	1980

Other funds holding ATRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

MWP

MYCIO Wealth Partners Philadelphia, Pennsylvania $502M AUM 11.65% 1-Year Est. Return

M&T Bank's ATRS Position: Q3 2019 in Review

M&T Bank sold out of Antares Pharma, Inc. (ATRS) in Q3 2019, closing a stake of 30,000 shares — an estimated $99K sold.

M&T Bank first reported a position in ATRS in Q2 2015 and held it in 11 quarters. The position peaked at $421K in Q3 2017. 135 funds tracked by Wall St. Rank hold ATRS as of Q3 2019.

M&T Bank reported no remaining Antares Pharma, Inc. position as of Q3 2019 after selling out during the quarter.
M&T Bank sold 30,000 Antares Pharma, Inc. shares in Q3 2019, an estimated $99K.
M&T Bank first reported a position in Antares Pharma, Inc. in Q2 2015 and held it in 11 quarters.
M&T Bank's Antares Pharma, Inc. position peaked at $421K in Q3 2017.
135 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2019.

Based on M&T Bank's 13F filing for Q3 2019, filed 12 Nov 2019.